EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/276058
March 2014 by Erin L. Boyle EyeWorld Senior Staff Writer The Sunday Summit to highlight genetics, state of the art in subspecialties T his year's General Session on Sunday, A pril 27, The Sunday Summit, will offer attendees a chance to hear a renowned science writer discuss genetics in the ASCRS Lecture on Science and Medicine, and see a new program called "60 Minutes: Future Directions in Anterior Segment Surgery." "Each morning of the annual meeting, we have a General Session that starts the day, and each year we look at changing up our format," said Edward J. Holland, MD, chair of the ASCRS Program Committee. "This year, the Program Committee d ecided to change the format of the Sunday General Session, and we came up with this concept of The Sunday Summit." "We have two sessions for The Sunday Summit—the ASCRS Lecture on Science and Medicine and then a brand new program called '60 Minutes,'" he said. The Sunday Summit will run from 10:00 a.m. to 12 p.m., with the ASCRS Lecture on Science and Medicine from 10:00 to 11 a.m. and "60 Minutes: Future Directions in Anterior Segment Surgery" from 11:00 a.m. until 12 p.m. About The Sunday Summit The Sunday Summit will offer attendees a unique look at an interesting topic, as well as the latest from leading ophthalmologists in several subspecialties, all within two hours on Sunday morning. "We tried to pack an incredible amount of information that was clinically relevant, useful, and inter- esting into a small period of time," Dr. Holland said. "I don't think the audience will have an opportunity to get this at any other meeting. The Sunday Summit is a great chance for the ophthalmologist to hear some new and exciting clinical informa- tion." ASCRS Lecture on Science and Medicine This year's ASCRS Lecture on Science and Medicine will be given by Adam Rutherford, PhD, on "Creation: The History and Future of Life, DNA, and Genes." This lecture is always popular with attendees, Dr. Holland said, and features an expert in the field of medicine outside of ophthalmology who discusses topics of interest within the specialty. Dr. Rutherford is "a leader in this emerging field of evolution in genetics and synthetic human biology," Dr. Holland said. Dr. Rutherford holds a PhD from University College London. "He is a well-known speaker in Europe and a well-published author, and his latest book, Creation, has received praised from numerous publications, including The Wall Street Journal, Smithsonian Magazine, L.A. Times, and The Observer," Dr. Holland said. "We're very excited to have him and think he will be of great interest to our audience." 60 Minutes The new "60 Minutes: Future Direc- tions in Anterior Segment Surgery" will be moderated by Dr. Holland and feature a panel of experts including Eric D. Donnenfeld, MD, East Meadow, N.Y., Bonnie An Henderson, MD, Boston, and Richard A. Lewis, MD, Sacramento, Calif. Dr. Holland said this session in The Sunday Summit will be based on the television news show 60 Minutes and will feature parts of the show familiar to viewers. The pro- gram will showcase a series of talks on the future of anterior segment surgery by experts in numerous aspects of the field. "They will discuss the state of the art of each major subspecialty in ophthalmology and give their predictions for future trends in the next three to five years," he said. Donald TH Tan, FRCS, Singapore, will present the "Cornea Surgery" portion of the program; Thomas Kohnen, MD, Frankfurt, Germany, will present the "Presbyopia Correction" portion; Reay H. Brown, MD, Atlanta, will present the "Glaucoma Surgery" portion; Richard L. Lindstrom, MD, Minneapolis, will present the "Refractive Surgery" portion; David F. Chang, MD, Los Altos, Calif., will present the "Cataract Surgery" portion; and Kent Stiverson, MD, Denver, will present "An Alternative Model for Eye Care Delivery." "'60 Minutes' brings together world-class experts who will give their predictions of what's going to happen in the next few years, where we should all be in our practice in anterior segment surgery, so I think this information will be vital to ophthalmologists planning for the future," Dr. Holland said. EW Editors' note: Dr. Holland has no financial interests related to this article. Contact information Holland: eholland@holprovision.com A SCRS•ASOA Preview • A pril 25–29, 2014 the patient's central optical zone, the pr erred. When placed in the corneal str def ocedure can po or a corneal transplant pr f ored and the need y be rest that their functional vision ma oconus (K erat and astigmatism in patients with k or the reduction or elimination of m vice designed f de plants are an ophthalmic medical Corneal Im ® Intacs DEVICE DESCRIPTION oduct reduces the patient's central optical zone, the pr oma, outside of erred. When placed in the corneal str entially be t ocedure can po ored and the need C) so oconus (K opia y or the reduction or elimination of m plants are an ophthalmic medical H L W D S F L Q R F R W D U H N I R W H V E X V F À L F H S V H K 7 entially be def t y po ocedure ma cornea transplant pr o red and the need f ybe rest their functional vision ma vision with their contact lenses or spectacles, so that o achie oconus who are no longer able t erat k opia and astigmatism in patients with y or elimination of m ended f plants are int Corneal Im ® Intacs TION INTENDED USE/ INDICA AT replacement, if desired. o allo oduct has been designed t Intacs pr uidistant on each side of the incision. The o be placed eq t W Q , H K 7 G H W D H U W H E R W H \ H F À L F H S V H K W Q L erat astigmatic axis and the amount of k y depending on the ar y v er ma v e w poral, ho em typically t oma. The placement of the incision will be corneal str ough a small radial incision in the ed thr t surgically inser ds depth, and are o thir ely tw ximat o the cornea, at appr o be placed in the peripher segments are designed t oconus, repositions the cone centrally erat k R I G Q D D H Q U R F H K W J Q L Q H W W D Á \ E H Q R F H K W the patient's central optical zone, the pr H E R W G H V R S R U S V W Q erred. entially be def o r a ored and the need f vision with their contact lenses or spectacles, so that e uat e adeq v o achie opia and astigmatism in patients with or the reduction al or v w remo o allo uidistant on each side of the incision. The H U D V W Q H P J H V V F D oconus present erat y depending on the oma. The placement of the incision will be ough a small radial incision in the ds depth, and are y of o be placed in the peripher . Intacs oconus, repositions the cone centrally O D U W Q H F Q R Q U R oduct reduces the patient's central optical zone, the pr n ditions, su lar co cu nce of o se pre In the • n; ome sing w r nu gnant or e In pr • V H V D H V L G \ F Q H L F À H G R Q X P P L , au lar ascu n v llage nts with co In patie • ; e n sit d incisio se po o pr 4 9 micr f 4 ss o al thickne rne a co e v ha rmally thin cor abno e v ha nts who In patie • e d: contraindicat o conus are erat or k plants f Intacs Corneal Im T IONS C ONTRAINDICA A T n al visio nctio ir fu e the v o pr im o n t ptio o n as the al transplantatio rne co e v ha Who • and; e n sit d incisio se opo at the pr f 450 micr ss o al thickne rne a co e v ha Who • a s; ne al cor ntr ar ce cle e v ha Who • r ; lde r o o f age s o ar e 1 y 2 are Who • s; ctacle r spe s o ntact lense co n a daily basis with the n o nal visio nctio fu e at u q ade y can no ch that the n, su ir visio in the e ssiv gre o a pr d nce rie xpe e e v ha Who • plants are those patients: ed with intacs corneal Im treat S S n t re r cu e ch as r nditions, su or ne immu o t , au s s at the r le ons o 49 micr r who as o ne rmally thin cor o conus are n . nal visio maining nly re o n as the r e at r gre ons o f 450 micr i r n a daily basis with the e v r achie nge lo n ratio rio e t de p lants are those patients: S S d 0.350mm Intacs Cor e iv ce nts who re atie P • e. r ssu lar pre cu d intrao ase incre su ide ring Gu e nt m Ce u acu V f the o Use • U TIONS PRECA ) . e gre r de s pe cle .5 cy ncies (1 e u q fre at the e nsitiv ntract se loss in co me so nts ma ns, patie itio sopic cond r me e nd U • p ia clinical trials. o y .S. m U Q H H E H Y D K D W D G P U H W J Q R O O D Q R L W L G G $ n e e t be nsity has no ll de lial ce the ndo e D H Q U R & V F D W Q , I R W F H I H I H P U H W J Q R O H K 7 • pr o appr ld be shou ly and e rativ ope st po w light visu o lo d t se dispo pre mm) are p il diame pu d e dilat nts with large patie Some • A RNINGS W m atriptan. ); su 2 o ne r ace P ne o dar in; amio tino tre ications: iso d me r more o ne taking o are nts who In patie • r e tu o fu nt t patie the se ispo d y pre ma r neal dystr co or me o r n synd sio o r al e rne co n ditions, su lar co cu nce of o se pre In the • a l ne d 0.350mm Intacs Cor o t e y cts the e bje su w spatial lo at the n ce rie xpe y e nts ma H K W Q L G H W F H O O R F d . stablishe n e Q R V W Q D O S P , O D . d vise ly ad e iat pr m s o pt al sym w light visu . 0 s (>7 r e t pil diame r o 1 o ne ar d r (Co ne wing ollo f of the r more r ns; o plicatio m co , that y oph rneal dystr n t re r cu e ch as r nditions, su rne ntral co in ce ase cre y de rar po m e A t • s . adache he m atriptan f taking su nts who are patie m me co t re no plants are al Im rne Intacs Co • . r e s zost pe r He f ophthalmic He y o r o nts with a hist patie m me co t re no plants are al Im rne Intacs Co • p lants. al Im rne the Intacs Co r ne nt of co u amo e at u q r an ade o w f o a llo a st 350 micr at le be ne ptical zo 9mm o o 6mm t a l thickne rne co d that the nde comme It is re • . ase pic dise o at G W Q H G Q H S H G Q L O X V Q L V D K F X V J Q L O D H K l y t e s lik ase ise mic d e nts with syst patie m me co t re no plants are al Im rne Intacs Co • s . tcome u ir o n with the actio dissatisf o t 0.350mm patie r the o f e al rat v mo d re ase incre n ally dditio opia trial. A y .S. m U ing the r du p lants thickne al Im rne r Intacs Co the d o e iv ce re o patie d t pare as com me tco ou d ce du a re o pia e y nt of m atme tre the or plants f Im n has nsatio al se rne r migraine o fo d in nde mme x or ple s sim pe r f ophthalmic He d in nde mme e v abo e al tissu rne o ns t o ast 350 micr s s at the al thickne H U H Y H V U R V H W H E D L n d u o ct w e f e o af ly t d in nde mme s . e nts du 0.350mm patie a s an w re , the nally s sse plants thickne n ts who o patie d nce rie xpe opia e TIONS VERSE EVENTS/COMPLICA AT AD H V X P U H W J Q R O Q , • ns; or o micr ss le ral thickne riphe ns, or pe o micr ntral thickne as with a ce rne r co o F • f age s o ar e 1 y 2 r 2 nde r patients u o F • ma; r trau o s corne u vio r pre , o rmality al abno ne cor ystalline r cr the r o osis o r ar scle cle nu opia o y m e ssiv gre o nts with pr In patie • d: stablishe n e e T be NO e v ha plants f al Im rne f Intacs Co ty o e saf The • . rilize e est r r o se u t re no nly; do o d f e nd e int plants are al Im rne Intacs Co • d. stablishe e plants ha al Im rne al of Intacs Co v mo e the r al transplant pr rne r a co s o re du ce o pr rnativ e f alt ss o ne e ctiv e f f ty and e e saf The • pia clinical tr o y .S. m U d in the e nstrat mo e d re e w nts. No clinical co patie me d in so e t n no e be rne ntral co in ce ase cre y de rar po m e A t • 70 ss than 5 ss le ss than 480 ss le ntral thickne ; f age y r rge al su s corne , ns opacity le ystalline r astigmatism, opia o s nu oco rat e r k o plants f se u r single o d f n e t be no e v plants ha wing llo o f re u d ce o al transplant pr e fractiv e r e rnativ ials. pia clinical tr s nce e u q nse nts. No clinical co n has nsatio al se rne ations during the m v alent ocular obser v The most pre D V L W L U L V L W L H Y X U R L U H W Q D H W D U W O À Q L O D H Q U R F T D H S D J Q R L V L F Q L H J U D K F V L G O D Y L W F Q X M Q R F ascularization (pannus), v ormation, neo epithelial plug f reduction in central corneal sensation, ele epithelial cysts, induced astigmatism, a t H G X O F Q L V J Q L G Q À O D F L Q L O F G H W U R S H U U H K W 2 o an incorrect knif ed t erior chamber relat ant O O D P V D G Q D V L W L W D U H N H Y L W D U W O À Q L H G X O F Q L ed adv t epor ue. R echniq with the surgical t ere primarily associat e been rare and w v opia ha y m ed during the clinical trials f t ents repor v se e er dv A en sand in his e tt ving go with a patient ha oreign body sensation associat al injection/f conjunctiv V D Y R H Q V L W L W D U H N U D O O H P D O V X R L W F H I Q L Q R Q U H S X V V P R W S P \ V O D X V L Y H ] D K O D Q R L V L F Q L Q D K F U D O O H P D O I R V J Q L G Q À O D F L Q L O F U D O L P L V oconus indicat erat or k on the use of Intacs segments f U H H S H K 7 D H U D Q R L V L F Q L H K W Q L H ] D K G Q D omal deposits on or near the intacs segments ere intrastr w operativ ed post t The most commonly repor VERSE EVENTS/COMPLICA opia y ations during the m H ] D K O D P R U W V G Q H U D Á V X R H X T ascularization (pannus), , ed IOP at v reduction in central corneal sensation, ele y porar em epithelial cysts, induced astigmatism, a t J Q L Q L D W V O D H Q U R F tting. e se o an incorrect knif H K W I R Q R L W D U R I U H S ents v se e er ed adv ed ere primarily associat or ical trials f for e. y en sand in his e ed oreign body sensation associat G Q D Q R L W D ] L U D O X F V W Q H P H F D O S O D L F À U V W L V R S H G O H Q es oconus indicat H U X W D U H W L O G H Z H L Y H U omal deposits on or near the intacs segments ations v e obser operativ ories. Laborat I R N U D P H G D U W G H U H W V L J H U D V L H Q R U H F D 3 2 R N U D P H G D U W G H U H W V L J H U D V L H Q R U D G U R & 1 ving visual sym o ha y predispose the patient t ma .0 mm in diame patient has a large pupil (>7 er time, unless the v o decrease o ends t ects t f side ef e that the incidence of these visual opia indicat y and m or bo uality of vision. The clinical results f q R L V L Y W K J L Q K W L Z \ W O X F À IÀ L G V H J D P L H O E X R G V R O D K H U D O J H G X O F Q L V W F H I I H H G L V H V H K W ects. The most pre f tain visual side ef ed cer t repor opia indications, ha y oconus and m erat th the k bo atients undergoing the Intacs surgical pr P injection and lamellar tunnel deposits. ere lamellar tunnel haze, conjunctiv clinical trials w ations during the m v alent ocular obser v The most pre K W L P 6 U H K V S 8 À R Q D 6 I oms. pt ving visual sym er), which t .0 mm in diame er time, unless the e that the incidence of these visual oconus erat th k or bo G H V D H U F H G G Q D Q R Q R L V L Y J Q L W D X W F X Á alent of v ects. The most pre e v opia indications, ha or ocedure, f atients undergoing the Intacs surgical pr al ere lamellar tunnel haze, conjunctiv opia y ations during the m Adam Rutherford, PhD, will give the ASCRS Lecture on Science and Medicine. Source: Adam Rutherford, PhD 48-63 Boston Preview_EW March 2014-DL_Layout 1 3/6/14 7:28 PM Page 62